PolyPid Ltd
PYPD3.970USD
+0.050+1.28%
收盘 12/19, 16:00（美东）报价延迟15分钟
66.04M总市值
亏损市盈率 TTM
关于 PolyPid Ltd 公司
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
PolyPid Ltd简介
公司代码PYPD
公司名称PolyPid Ltd
上市日期Jun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
员工数量57
证券类型Ordinary Share
年结日Jun 26
公司地址18 Hasivim Street, P.O Box 7126
城市PETAH TIKVA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Israel
邮编4917002
电话972747195700
网址https://www.polypid.com
公司代码PYPD
上市日期Jun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
PolyPid Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
+100.00%
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Mr. Chaim Hurvitz
Mr. Chaim Hurvitz
Independent Director
Independent Director
--
--
Dr. Shaul Mukhtar, Ph.D.
Dr. Shaul Mukhtar, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ms. Dalit Hazan
Ms. Dalit Hazan
Senior Vice President - Research and Development and Regulatory Affairs
Senior Vice President - Research and Development and Regulatory Affairs
--
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Robert Burton (Bob) Stein, M.D., Ph.D.
Dr. Robert Burton (Bob) Stein, M.D., Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
+100.00%
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Mr. Chaim Hurvitz
Mr. Chaim Hurvitz
Independent Director
Independent Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Aurum Ventures M.K.I.
18.53%
Centaurus Investments Limited
6.66%
Rosalind Advisors, Inc.
5.52%
AIGH Capital Management, LLC.
4.64%
Nir (Yehuda)
3.69%
其他
60.96%
持股股东
持股股东
占比
Aurum Ventures M.K.I.
18.53%
Centaurus Investments Limited
6.66%
Rosalind Advisors, Inc.
5.52%
AIGH Capital Management, LLC.
4.64%
Nir (Yehuda)
3.69%
其他
60.96%
股东类型
持股股东
占比
Venture Capital
18.66%
Hedge Fund
10.77%
Holding Company
6.66%
Individual Investor
5.52%
Private Equity
4.64%
Corporation
3.53%
Investment Advisor/Hedge Fund
1.76%
Research Firm
1.36%
Investment Advisor
1.22%
其他
45.87%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
28
6.76M
43.18%
+2.23M
2025Q2
41
7.60M
74.58%
+1.39M
2025Q1
42
7.66M
75.16%
+942.60K
2024Q4
44
5.48M
65.20%
+1.87M
2024Q3
50
4.47M
69.98%
+1.49M
2024Q2
58
3.43M
73.51%
+1.59M
2024Q1
59
3.33M
71.29%
+2.56M
2023Q4
54
443.78K
34.10%
+80.67K
2023Q3
57
479.04K
37.01%
+97.48K
2023Q2
57
472.86K
36.65%
+91.51K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Aurum Ventures M.K.I.
3.08M
19.69%
+1.06M
+52.19%
Jun 30, 2025
Centaurus Investments Limited
1.11M
7.08%
+475.10K
+75.12%
Dec 31, 2024
Rosalind Advisors, Inc.
975.46K
6.23%
-42.56K
-4.18%
Jun 30, 2025
AIGH Capital Management, LLC.
462.54K
2.95%
-48.41K
-9.47%
Jun 30, 2025
Nir (Yehuda)
613.91K
3.92%
+62.60K
+11.36%
Mar 31, 2025
Hewlett Fund, L.P.
587.92K
3.76%
+338.44K
+135.66%
Feb 26, 2025
Triple Gate Capital, LP
465.84K
2.98%
+465.84K
--
Feb 26, 2025
Lukach (Aharon)
299.55K
1.91%
-5.64K
-1.85%
Mar 31, 2025
Worth Venture Partners, LLC
731.57K
4.67%
+302.14K
+70.36%
Jun 30, 2025
Dafna Capital Management, LLC
207.90K
1.33%
-83.37K
-28.62%
Jun 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
公告日期
类型
比率
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
常见问题
PolyPid Ltd的前五大股东是谁？
PolyPid Ltd 的前五大股东如下：
Aurum Ventures M.K.I.持有股份：3.08M，占总股份比例：19.69%。
Centaurus Investments Limited持有股份：1.11M，占总股份比例：7.08%。
Rosalind Advisors, Inc.持有股份：975.46K，占总股份比例：6.23%。
AIGH Capital Management, LLC.持有股份：462.54K，占总股份比例：2.95%。
Nir (Yehuda)持有股份：613.91K，占总股份比例：3.92%。
Aurum Ventures M.K.I.持有股份：3.08M，占总股份比例：19.69%。
Centaurus Investments Limited持有股份：1.11M，占总股份比例：7.08%。
Rosalind Advisors, Inc.持有股份：975.46K，占总股份比例：6.23%。
AIGH Capital Management, LLC.持有股份：462.54K，占总股份比例：2.95%。
Nir (Yehuda)持有股份：613.91K，占总股份比例：3.92%。
PolyPid Ltd的前三大股东类型是什么？
PolyPid Ltd 的前三大股东类型分别是：
Aurum Ventures M.K.I.
Centaurus Investments Limited
Rosalind Advisors, Inc.
Aurum Ventures M.K.I.
Centaurus Investments Limited
Rosalind Advisors, Inc.
有多少机构持有PolyPid Ltd(PYPD)的股份？
截至2025Q3，共有28家机构持有PolyPid Ltd的股份，合计持有的股份价值约为6.76M，占公司总股份的43.18%。与2025Q2相比，机构持股有所增加，增幅为-31.40%。
哪个业务部门对PolyPid Ltd的收入贡献最大？
在--，--业务部门对PolyPid Ltd的收入贡献最大，创收--，占总收入的--%。
